Accenture plc (ACN) Drawdown History

50 recorded drawdown events with recovery analysis

Price

$198.95

All-Time High

$394.31

Current Drawdown

-49.5%

Severity Score

11.5

Zone

Extreme

Drawdown Distribution

How ACN's 50 recorded drawdowns break down by severity:

45

< 5%

3

5-10%

1

10-20%

0

20-30%

1

30%+

Recovery Patterns

When ACN drops 10% or more from its high, it has happened 2 times with an average duration of 609 days and an average maximum drop of -26.5%.

Drops of 20% or more have occurred 1 times, lasting an average of 1134 days with an average depth of -39.7%.

All Drawdown Events

Showing 5 events with drops of 5% or more, sorted by depth.

#Start DateEnd DateMax DropDurationStart PriceLow Price
12021-12-302025-02-05-39.7%1134 days$391.45$236.09
22020-09-032020-11-24-13.3%83 days$229.18$198.80
32020-12-212021-03-11-8.8%81 days$247.82$225.95
42021-09-162021-10-19-7.2%34 days$323.59$300.16
52021-11-182021-12-08-5.1%21 days$351.27$333.20

45 minor events (under 5% drop) not shown.

Frequently Asked Questions

What is ACN's biggest all-time drawdown?

Accenture plc's deepest recorded drawdown was -39.7%, which occurred from 2021-12-30 to 2025-02-05 and lasted 1134 days. The stock dropped from $391.45 to a low of $236.09.

How long does it take ACN to recover from a drawdown?

When ACN drops 10% or more from its high, it has historically recovered within an average of 609 days. This is based on 2 comparable events in the tracked history.

Is ACN at an all-time high?

No, Accenture plc is currently trading at $198.95, which is -49.5% below its all-time high of $394.31. The current Drawdown Severity Score is 11.5 (Extreme).

How many drawdown events has ACN experienced?

Accenture plc has experienced 50 tracked drawdown events. Of these, 5 were drops of 5% or more. The average maximum drawdown across all events is -3.5%.

Track ACN's Severity Score

Set custom alerts for Accenture plc and get notified when it crosses into new severity zones.

Get Started Free

Disclaimer: DrawdownAlerts provides historical data analysis, not financial advice. Past performance does not guarantee future results. Severity scores are analytical tools, not buy/sell signals. Always do your own research before making investment decisions.